What's the Golden Dose on Mounjaro — and How Do You Find Yours?

Step 1, Why 2.5mg exists and what it is actually doing

Mounjaro's licensed titration begins at 2.5mg, and it is worth being clear about the purpose of that first pen: it is a settling-in dose. Its job is to introduce tirzepatide's dual GIP and GLP-1 action to your system gradually, reducing the likelihood of the nausea and digestive discomfort that can hit if the dose starts too high. Most people notice relatively modest appetite changes at this level, that is expected. If you feel frustrated that the scale isn't shifting much in the first four weeks, you are not doing anything wrong. The 2.5mg period is part of the design, not a delay. What actually happens at 2.5mg is covered in more detail if you want to dig into that specific stage.

Once four weeks have passed, a prescriber reviews your response before the step to 5mg. That review matters, it is not a formality. It checks that you are tolerating treatment and that continuing is clinically appropriate.

Step 2, 5mg and the dose people often call the golden dose

The 5mg pen is where a noticeable shift tends to arrive. Appetite suppression becomes more pronounced for many people, eating patterns begin to change, and weight loss starts to feel real rather than theoretical. This is the level that online communities frequently label the "golden dose on Mounjaro," and it is easy to see why: for a significant proportion of patients, the balance between effect and tolerability feels genuinely good here.

That said, "good enough for the community" and "right for you" are different questions. Whether 5mg is truly the golden dose for your situation depends on how much weight you are trying to lose, how you respond individually, and what your prescriber observes over time. Some people find 5mg sustains progress for months; others plateau and need to step further up the schedule. Both are normal.

Mounjaro is available in six UK strengths (2.5, 5, 7.5, 10, 12.5 and 15mg) and the 5mg pen sits at the lower-middle of that range, not at the ceiling.

Step 3, When to consider going higher, and what the evidence shows

In the SURMOUNT-1 trial (2,539 adults with obesity), average body-weight reduction at the highest dose reached approximately 20 to 21% over 72 weeks, considerably more than was seen at the lower therapeutic doses. The full Mounjaro overview outlines those results in context. The clinical picture is clear: in the trial data, higher doses produced greater weight loss, which is why NICE's recommendation for tirzepatide (published in December 2024 as TA1026) specifies continuing only if meaningful progress is being made, with the option to move to the highest tolerated dose.

This is where the golden-dose idea gets nuanced. If you have found a dose that feels comfortable, it is natural to want to stay there. But "comfortable" and "working as well as it could" are not always the same thing. A prescriber's role is to weigh your weight-loss progress, your tolerability, and your goals together, and to advise whether holding or stepping up serves you better. That is a clinical conversation, not something to decide by browsing forums.

For context on where the titration can ultimately lead, the highest licensed dose of Mounjaro in the UK is 15mg, reached in gradual steps over many months.

Step 4 (Staying at your golden dose and what ongoing review looks like

Once you reach a dose where weight loss is consistent and you are tolerating treatment well, that is your working golden dose) until something changes. Weight loss can slow at any level after months of treatment; that is not failure, it is physiology. Your prescriber will assess progress at each repeat review before your next supply is issued.

A question our prescribers hear regularly: "can I just stay at my golden dose forever?" The answer depends on your response. Some people hold a mid-range dose for the duration of treatment. Others find that a further step is warranted. Whether your golden dose counts as a full therapeutic dose is worth understanding clearly, because it affects how you and your prescriber interpret your progress.

It is also worth knowing that the UK list price for Mounjaro has changed significantly, Eli Lilly raised prices from September 2025, and what that means for private treatment costs is something many patients ask about when planning ahead. The nume consultation gives you space to raise those practical questions alongside the clinical ones. Our prescribers review every consultation personally (no automated decision-making) and that review happens the same day you submit. If you are ready to find your own golden dose with proper clinical support, starting that conversation costs nothing.